According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$2.28. In 2022 the company made an earnings per share (EPS) of -$1.96 an increase over its 2021 EPS that were of -$2.36.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.37 | 21.25% |
2022 | -$1.96 | -17.05% |
2021 | -$2.36 | 74.26% |
2020 | -$1.35 | -283.64% |
2019 | $0.74 | -257.14% |
2018 | -$0.47 | -27.08% |
2017 | -$0.64 | -59.32% |
2016 | -$1.58 | -21.85% |
2015 | -$2.02 | 9.42% |
2014 | -$1.85 | 2.87% |
2013 | -$1.80 | -31.56% |
2012 | -$2.63 | 300% |
2011 | -$0.66 | -45.56% |
2010 | -$1.21 | -66.67% |
2009 | -$3.62 | -63.51% |
2008 | -$9.92 | -12.94% |
2007 | -$11.40 | 44.07% |
2006 | -$7.91 | 77.35% |
2005 | -$4.46 | 10.66% |
2004 | -$4.03 | -54.25% |
2003 | -$8.81 | -80.51% |
2002 | -$45.20 | 3.87% |
2001 | -$43.52 | 116.17% |
2000 | -$20.13 |